BDXBecton Dickinson
Is it safe?
Strong, no red flags: a safe balance sheet.
Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.
Insiders were net sellers (-$1.3M, 90 days to Oct 8, 2026), selling is often routine.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -40% · now 4% below its 52-week high.
Unless marked, from SEC EDGAR, as of Sep 30, 2025.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can BDX take a bad year?
Becton Dickinson carries $16.1B of net debt at 3.23× EBITDA: a load its earnings can carry.
Net debt · as at Q3 2026 · between two and four years of EBITDA, normal for a stable business
- Net debt / EBITDA
- 3.23×
Net debt / EBITDA · 4.10× a year ago · the load is coming down
- Altman Z-score
- 1.82
Altman Z-score · grey zone, between 1.8 and 3
- Debt / equity
- 0.69×
Debt / equity
Details›
- Total debtQ3 2026
- $16.8B
- Cash and short-term investments
- $709M
- Net debt
- $16.1B
- EBITDA, trailing twelve months
- $4.98B
- Operating profit, trailing twelve months
- $2.48B
- Debt / equity
- 0.69×
- Total debt / EBITDA
- 3.38×
- Annualised volatilitytwo years of daily moves
- 28%
- Worst drawdown on file
- −40%
- Below its 52-week high
- 4.3%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
The closest names by size in the same industry